These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Attenuation of the progression of adjuvant-induced arthritis by 3-aminobenzamide treatment.
    Author: Ahmad SF, Attia SM, Zoheir KM, Ashour AE, Bakheet SA.
    Journal: Int Immunopharmacol; 2014 Mar; 19(1):52-9. PubMed ID: 24444779.
    Abstract:
    Rheumatoid arthritis (RA) is a disease that is still insufficiently controlled by current treatments. Poly(ADP-ribose) polymerase (PARP) inhibitors ameliorate immune-mediated diseases in several experimental models, including RA, colitis, experimental autoimmune encephalomyelitis and allergy. Together these findings showed that ADP-ribosylating enzymes, in particular PARP-1, play a pivotal role in the regulation of immune responses and may represent a noble target for new therapeutic approaches in immune-mediated diseases. The effect of 3-aminobenzamide (3-AB), an inhibitor of poly(ADP-ribose) synthetase activity, was evaluated in a mouse model of adjuvant-induced arthritis (AIA) on pro-inflammatory cytokines, adhesion molecules, inflammatory mediators and chemokine production/expression in serum and knee joint. Histopathological examination was also done on joint section. Our data demonstrates that 3-AB, 10mg/kg, intraperitoneally (i.p.) significantly reduces pro-inflammatory cytokine (IL-17, TNF-α and IL-2) and chemokine (MCP-1 and MIP-2) production/expression, accompanied by amelioration of the disease as indicated by reduced paw swelling and arthritic scores and was associated with a significant reduction of VCAM-1 and ICAM-1 expression in the knee joint. Moreover, the expression of inflammatory mediators (iNOS, COX-2, MMP-2, MMP-9) and joint histological inflammatory damage was also markedly decreased. The results of this study suggest that PARP-1 inhibitor may play a role in the inflammatory arthritic process after administration of 3-AB may be a beneficial therapeutic approach.
    [Abstract] [Full Text] [Related] [New Search]